接口广告
摩熵化学
数据开放平台 数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Cyto5F4

中文名称
——
中文别名
——
英文名称
Cyto5F4
英文别名
(1,4-dioxonaphthalen-2-yl) 4-methylbenzoate
Cyto5F4化学式
CAS
——
化学式
C18H12O4
mdl
——
分子量
292.3
InChiKey
DYTZMZHJBZDCNH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    22
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.06
  • 拓扑面积:
    60.4
  • 氢给体数:
    0
  • 氢受体数:
    4

文献信息

  • CHEMICAL AGENTS FOR THE PREVENTION OF INHIBITION OR TUMOR METASTASIS
    申请人:Bresnick Anne R.
    公开号:US20130090355A1
    公开(公告)日:2013-04-11
    The present invention provides methods of preventing or inhibiting tumor metastasis in a subject by administering a therapeutically effective amount of (1) a compound from a group of enumerated compounds, or a pharmaceutically acceptable salt thereof; (2) an agent that covalently modifies at least one cysteine residue of S100A4 protein; or (3) an agent that inhibits the interaction between S100A4 and myosin-IIA.
  • [EN] METHOD AND COMPOSITIONS FOR INHIBITION OF MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF)<br/>[FR] PROCÉDÉS ET COMPOSITIONS POUR INHIBER LE FACTEUR D'INHIBITION DE LA MIGRATION DES MACROPHAGES (MIF)
    申请人:ECOLE POLYTECH
    公开号:WO2011066864A1
    公开(公告)日:2011-06-09
    The present invention relates to methods for inhibition of tautomerase activity of macrophage migration inhibitory factor (MIF). The invention further relates to substances for irreversibly covalently binding to MIF for inhibition of tautomerase activity.
  • [EN] CHEMICAL AGENTS FOR THE PREVENTION OR INHIBITION OF TUMOR METASTASIS<br/>[FR] AGENTS CHIMIQUES POUR LA PRÉVENTION OU L'INHIBITION DE MÉTASTASES TUMORALES
    申请人:EINSTEIN COLL MED
    公开号:WO2011146101A1
    公开(公告)日:2011-11-24
    The present invention provides methods of preventing or inhibiting tumor metastasis in a subject by administering a therapeutically effective amount of (1) a compound from a group of enumerated compounds, or a pharmaceutically acceptable salt thereof; (2) an agent that covalently modifies at least one cysteine residue of S100A4 protein; or (3) an agent that inhibits the interaction between S100A4 and myosin-IIA.
查看更多